Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Primary Care
Published in: BMC Primary Care 1/2016

Open Access 01-12-2016 | Research article

“It’s complicated” - talking about gout medicines in primary care consultations: a qualitative study

Authors: Caroline Morris, Lindsay Macdonald, Maria Stubbe, Anthony Dowell

Published in: BMC Primary Care | Issue 1/2016

Login to get access

Abstract

Background

Gout is the most common form of inflammatory arthritis. It is associated with substantial co-morbidity and often managed in primary care. A greater understanding of the communication process between patients and healthcare professionals provides one way of improving the management of this condition. This paper describes communication about gout medicines and treatment between patients and primary care health professionals during routine consultations.

Methods

Video-recordings of 31 individual healthcare consultations between patients and a range of primary care practitioners (general practitioners, practice nurses, podiatrists, dietitians) from an archived database were reviewed. Consultations that encompassed any discussion about gout medicines and treatment were included (n = 27) and were not solely restricted to those where gout was the presenting complaint. Themes were derived from an inductive qualitative analysis, from clinical and linguistic perspectives, based on the conversation between patients and practitioners about medicines and visual observation of these interactions.

Results

A number of factors were identified that had the potential to impact on the optimal management of gout in primary care. These included level of patient knowledge, patient attitudes to medicines, and the attributes of practitioner communication with patients. The latter related to the style of delivery and content of the information provided, and the ability of practitioners to make use of opportunities that arose to discuss these issues.

Conclusions

Patients with gout communicate at varying levels of complexity with a diverse range of primary care healthcare professionals about the treatment of their condition. It is important that all practitioners engaging with gout patients in this setting are knowledgeable about the current management of gout, provide clear, consistent and accurate messages, remain aware that these messages may need repeating over time, and are supportive of patients’ medicine-taking preferences.
Literature
1.
2.
Kuo C-F, See L-C, Luo S-F, Ko Y-S, Lin Y-S, Hwang J-S, et al. Gout: an independent risk factor for all-cause and cardiovascular mortality. Rheumatology. 2010;49:141–6.CrossRefPubMed
3.
Kuo C-F, Grainge MJ, Mallen C, Zhang W, Doherty M. Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study. Ann Rheum Dis. 2015;74:661–7
4.
5.
Anon. An update on the management of gout. Best Pract J. 2013;51:8–14.
6.
Jordan KM, Cameron JS, Snaith M, Zhang W, Doherty M, Seckl J, et al. British Society for Rheumatology and British Health Professionals in Rheumatology Guideline for the Management of Gout. Rheumatology. 2007;46(8):1372–4.CrossRefPubMed
7.
Zhang W, Doherty M, Bardin T, Pascual E, Barskova V, Conaghan P, et al. EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2006;65:1312–24.CrossRefPubMedPubMedCentral
8.
Khanna D, Fitzgerald JD, Khanna PP, Bae S, Singh MK, Neogi T, et al. 2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res. 2012;64:1431–46.CrossRef
9.
10.
Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Saag KG. Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: results from the UK General Practice Research Database (GPRD). Rheumatology. 2005;44:1038–42.CrossRefPubMed
11.
Annemans L, Spaepen E, Gaskin M, Bonnemaire M, Malier V, Gilbert T, et al. Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000–2005. Ann Rheum Dis. 2008;67:960–6.CrossRefPubMed
12.
Singh JA, Hodges JS, Toscano JP, Asch SM. Quality of care for gout in the US needs improvement. Arthritis Care Res. 2007;57:822–9.CrossRef
13.
Kuo C-F, Grainge MJ, Mallen C, Zhang W, Doherty M. Eligibility for and prescription of urate-lowering treatment in patients with incident gout in England. JAMA. 2014;312:2684–6.CrossRefPubMed
14.
Roddy E, Zhang W, Doherty M. Concordance of the management of chronic gout in a UK primary care population with the EULAR gout recommendations. Ann Rheum Dis. 2007;66:1311–5.CrossRefPubMedPubMedCentral
15.
Harrold LR, Mazor KM, Negron A, Ogarek J, Firneno C, Yood RA. Primary care providers’ knowledge, beliefs and treatment practices for gout: Results of a physician questionnaire. Rheumatology. 2013;52:1623–9.CrossRefPubMedPubMedCentral
16.
Dalbeth N. Management of gout in primary care: challenges and potential solutions. Rheumatology. 2013;52:1549–50.CrossRefPubMed
17.
Richardson JC, Liddle J, Mallen CD, Roddy E, Prinjha S, Ziebland S, et al. “Why me? I don’t fit the mould… I am a freak of nature”: a qualitative study of women’s experience of gout. BMC Womens Health. 2015; doi:10.​1186/​s12905-015-0277-z
18.
19.
Martini N, Bryant L, Karu LT, Aho L, Chan R, Miao J, et al. Living with gout in New Zealand: An exploratory study into people’s knowledge about the disease and its treatment. J Clin Rheumatol. 2012;18:125–9.CrossRefPubMed
20.
Te Karu L, Bryant L, Elley CR. Maori experiences and perceptions of gout and its treatment: a kaupapa Maori qualitative study. J Prim Health Care. 2013;5:214–22.
21.
Spencer K, Carr A, Doherty M. Patient and provider barriers to effective management of gout in general practice: A qualitative study. Ann Rheum Dis. 2012;71:1490–5.CrossRefPubMed
22.
Lindsay K, Gow P, Vanderpyl J, Logo P, Dalbeth N. The experience and impact of living with gout: a study of men with chronic gout using a qualitative grounded theory approach. J Clin Rheumatol. 2011;17:1–6.CrossRefPubMed
23.
Harrold LR, Mazor KM, Velten S, Ockene IS, Yood RA. Patients and providers view gout differently: a qualitative study. Chronic Ill. 2010;6:263–71.CrossRef
24.
25.
Boyatzis R. Thematic Analysis and Code Development: Transforming Qualitative Information. London: Sage Publications; 1998.
26.
Street Jr RL, Makoul G, Arora NK, Epstein RM. How does communication heal? Pathways linking clinician–patient communication to health outcomes. Patient Educ Couns. 2009;74:295–301.CrossRefPubMed
27.
Dowell A, Macdonald L, Stubbe M, Plumridge E, Dew K. Clinicians at work: What can we learn from interactions in the consultation? N Z Fam Physician. 2007;34:345–50.
28.
Harrold L, Mazor K, Peterson D, Naz N, Firneno C, Yood R. Patients’ knowledge and beliefs concerning gout and its treatment: a population based study. BMC Musculoskelet Disord. 2012. doi:10.​1186/​1471-2474-13-180.
29.
Stevenson FA, Cox K, Britten N, Dundar Y. A systematic review of the research on communication between patients and health care professionals about medicines: the consequences for concordance. Health Expect. 2004;7:235–45.CrossRefPubMed
30.
Politi MC, Dizon DS, Frosch DL, Kuzemchak MD, Stiggelbout AM. Importance of clarifying patients’ desired role in shared decision making to match their level of engagement with their preferences. Br Med J. 2013. doi:10.​1136/​bmj.​f7066.
31.
Paskins Z, Sanders T, Croft PR, Hassell AB. The identity crisis of osteoarthritis in general practice: a qualitative study using video-stimulated recall. Ann Fam Med. 2015;13:537–44.CrossRefPubMedPubMedCentral
32.
Metadata
Title
“It’s complicated” - talking about gout medicines in primary care consultations: a qualitative study
Authors
Caroline Morris
Lindsay Macdonald
Maria Stubbe
Anthony Dowell
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Primary Care / Issue 1/2016
Electronic ISSN: 2731-4553
DOI
https://doi.org/10.1186/s12875-016-0515-y

Other articles of this Issue 1/2016

BMC Primary Care 1/2016 Go to the issue

Research article

Interprofessional collaboration in nursing homes (interprof): a grounded theory study of general practitioner experiences and strategies to perform nursing home visits

Research article

A geriatric assessment in general practice: prevalence, location, impact and doctor-patient perceptions of pain

Research article

Combined effects of sleep quality and depression on quality of life in patients with type 2 diabetes

Research article

Perceptions of primary care staff on a regional data quality intervention in Australian general practice: a qualitative study

Research article

Typologies in GPs’ referral practice

Research article

The general practitioner workforce crisis in England: a qualitative study of how appraisal and revalidation are contributing to intentions to leave practice